IM Cannabis Corp. $IMCC reported second-quarter 2026 revenue of $5.4 million, down 42.8% from a year earlier, as gross profit fell to $1.1 million. Cost of sales declined to $4.3 million, but the company still faced significant pressure on profitability.
Operating results weakened further, with an operating loss of $1.5 million and net loss attributable to common shareholders of $3.1 million. Diluted loss per share came in at $0.33, while cash used in operating activities was $78,800.
On the balance sheet, cash and cash equivalents rose to $1.1 million, and total liabilities decreased to $21.3 million. The stock fell 1.9% after the market close.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
IM Cannabis Corp. Hedge Fund Activity
We have seen 4 institutional investors add shares of IM Cannabis Corp. stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADVISORSHARES INVESTMENTS LLC removed 102,120 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $37,784
- HERON BAY CAPITAL MANAGEMENT removed 25,875 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $9,573
- STONEX GROUP INC. added 23,215 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,909
- DRW SECURITIES, LLC removed 23,060 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,532
- BANK OF MONTREAL /CAN/ added 201 shares (+1.7%) to their portfolio in Q2 2026, for an estimated $33
- MORGAN STANLEY removed 100 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $37
- FEDERATION DES CAISSES DESJARDINS DU QUEBEC removed 3 shares (-0.2%) from their portfolio in Q1 2026, for an estimated $1
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
